Circulating markers of neutrophil activation and lung injury in pediatric pneumonia in low-resource settings

References

• Pneumonia. World Health Organization. Published 2021. [cited 2022 June 5]. Available from: https://www.who.int/news-room/fact-sheets/detail/pneumonia
   Google Scholar
• GH G, van ‘T Wout JW, NJ A, et al. Prediction model for pneumonia in primary care patients with an acute respiratory tract infection: role of symptoms, signs, and biomarkers. BMC Infect Dis. 2019;19(1):976. DOI:10.1186/s12879-019-4611-1
   PubMed Web of Science ®Google Scholar
• Cherian T, Mulholland EK, Carlin JB, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ. 2005;83(5):353–359.
   PubMed Web of Science ®Google Scholar
• Enwere G, Cheung YB, Zaman SM, et al. Epidemiology and clinical features of pneumonia according to radiographic findings in Gambian children. Trop Med Int Health. 2007;12(11):1377–1385. DOI:10.1111/j.1365-3156.2007.01922.x
   PubMed Web of Science ®Google Scholar
• Zar HJ, Andronikou S, Nicol MP. Advances in the diagnosis of pneumonia in children. BMJ. 2017;358:j2739.
   PubMedGoogle Scholar
• Izadnegahdar R, Cohen AL, Klugman KP, et al. Childhood pneumonia in developing countries. Lancet Respir Med. 2013;1(7):574–584.
   PubMed Web of Science ®Google Scholar
• WHO. Pocket book of hospital care for children: guidelines for the management of common illnesses with limited resources. 2 ed. Geneva: World Health Organization; 2013.
   Google Scholar
• WHO. Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization. 2014.
   Google Scholar
• Huang H, Ideh RC, Gitau E, et al. Discovery and validation of biomarkers to guide clinical management of pneumonia in African children. Clin Infect Dis. 2014;58(12):1707–1715. DOI:10.1093/cid/ciu202
   PubMed Web of Science ®Google Scholar
• Williams PCM, Isaacs D, Berkley JA. Antimicrobial resistance among children in sub-Saharan Africa. Lancet Infect Dis. 2018;18(2):e33–44.
   PubMed Web of Science ®Google Scholar
• Hazir T, Nisar YB, Abbasi S, et al. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan. Clin Infect Dis. 2011;52(3):293–300. DOI:10.1093/cid/ciq142
   PubMed Web of Science ®Google Scholar
• Gunaratnam LC, Robinson JL, Hawkes MT. Systematic review and meta-analysis of diagnostic biomarkers for pediatric pneumonia. J Pediatric Infect Dis Soc. 2021;10(9):891–900.
   PubMed Web of Science ®Google Scholar
• Dela Cruz CS, Liu W, He CH, et al. Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses. Cell Host Microbe. 2012;12(1):34–46. DOI:10.1016/j.chom.2012.05.017
   PubMed Web of Science ®Google Scholar
• Lee CG, Da Silva CA, Dela Cruz CS, et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73:479–501.
   PubMed Web of Science ®Google Scholar
• De Lorenzo R, Sciorati C, Lorè NI, et al. Chitinase-3-like protein-1 at hospital admission predicts COVID-19 outcome: a prospective cohort study. Sci Rep. 2022;12(1):7606. DOI:10.1038/s41598-022-11532-x
   PubMed Web of Science ®Google Scholar
• Spoorenberg SM, Vestjens SM, Rijkers GT, et al. YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia. Respirology. 2017;22(3):542–550. DOI:10.1111/resp.12924
   PubMed Web of Science ®Google Scholar
• Wang HL, Hsiao PC, Tsai HT, et al. Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients. Int J Mol Sci. 2013;14(11):22817–22825.
   PubMed Web of Science ®Google Scholar
• Sawatzky J, Soo J, Conroy AL, et al. Biomarkers of systemic inflammation in Ugandan infants and children hospitalized with respiratory syncytial virus infection. Pediatr Infect Dis J. 2019;38(8):854–859. DOI:10.1097/INF.0000000000002343
   PubMed Web of Science ®Google Scholar
• Sorensen GL. Surfactant protein D in respiratory and non-respiratory diseases. Front Med. 2018;5:18.
   PubMed Web of Science ®Google Scholar
• Saleh NY, Ibrahem RAL, Saleh AAH, et al. Surfactant protein D: a predictor for severity of community-acquired pneumonia in children. Pediatr Res. 2022;91(3):665–671.
   PubMed Web of Science ®Google Scholar
• Todd DA, Marsh MJ, George A, et al. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children. Pediatr Crit Care Med. 2010;11(1):82–91. DOI:10.1097/PCC.0b013e3181ae5a4c
   PubMed Web of Science ®Google Scholar
• Kawasaki Y, Endo K, Suyama K, et al. Serum SP-D levels as a biomarker of lung injury in respiratory syncytial virus bronchiolitis. Pediatr Pulmonol. 2011;46(1):18–22. DOI:10.1002/ppul.21270
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Nguyen A, Newhams MM, et al. Surfactant protein D is a biomarker of influenza-related pediatric lung injury. Pediatr Pulmonol. 2022;57(2):519–528. DOI:10.1002/ppul.25776
   PubMed Web of Science ®Google Scholar
• Dahmer MK, Flori H, Sapru A, et al. Surfactant protein D is associated with severe pediatric ARDS, prolonged ventilation, and death in children with acute respiratory failure. Chest. 2020;158(3):1027–1035. DOI:10.1016/j.chest.2020.03.041
   PubMed Web of Science ®Google Scholar
• Guardado S, Ojeda-Juárez D, Kaul M, et al. Comprehensive review of lipocalin 2-mediated effects in lung inflammation. Am J Physiol Lung Cell Mol Physiol. 2021;321(4):L726–733.
   PubMed Web of Science ®Google Scholar
• Warszawska JM, Gawish R, Sharif O, et al. Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J Clin Invest. 2013;123(8):3363–3372. DOI:10.1172/JCI67911
   PubMed Web of Science ®Google Scholar
• Yeh YH, Chang JL, Hsiao PC, et al. Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia. J Clin Lab Anal. 2013;27(4):253–260. DOI:10.1002/jcla.21588
   PubMed Web of Science ®Google Scholar
• Elkington PT, O’Kane CM, Friedland JS. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol. 2005;142(1):12–20.
   PubMed Web of Science ®Google Scholar
• Ries C. Cytokine functions of TIMP-1. Cell Mol Life Sci. 2014;71(4):659–672.
   PubMed Web of Science ®Google Scholar
• Lagente V, Boichot E. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J Mol Cell Cardiol. 2010;48(3):440–444.
   PubMed Web of Science ®Google Scholar
• Allen JR, Ge L, Huang Y, et al. TIMP-1 promotes the immune response in influenza-induced acute lung injury. Lung. 2018;196(6):737–743. DOI:10.1007/s00408-018-0154-2
   PubMed Web of Science ®Google Scholar
• Wollin L, Maillet I, Quesniaux V, et al. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. J Pharmacol Exp Ther. 2014;349(2):209–220.
   PubMed Web of Science ®Google Scholar
• Chiang TY, Yu YL, Lin CW, et al. The circulating level of MMP-9 and its ratio to TIMP-1 as a predictor of severity in patients with community-acquired pneumonia. Clin Chim Acta. 2013;424:261–266.
   PubMed Web of Science ®Google Scholar
• Bircan HA, Çakir M, Yilmazer Kapulu I, et al. Elevated serum matrix metalloproteinase-2 and -9 and their correlations with severity of disease in patients with community-acquired pneumonia. Turk J Med Sci. 2015;45(3):593–599.
   PubMed Web of Science ®Google Scholar
• Fleming S, Thompson M, Stevens R, et al. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011;377(9770):1011–1018. DOI:10.1016/S0140-6736(10)62226-X
   PubMed Web of Science ®Google Scholar
• Baggett HC, Watson NL, Deloria Knoll M, et al. Density of upper respiratory colonization with streptococcus pneumoniae and its role in the diagnosis of pneumococcal pneumonia among children aged <5 years in the PERCH study. Clin Infect Dis. 2017;64(suppl_3):S317–327. DOI:10.1093/cid/cix100
   PubMedGoogle Scholar
• Erdman LK, D’Acremont V, Hayford K, et al. Biomarkers of host response predict primary end-point radiological pneumonia in Tanzanian children with clinical pneumonia: a prospective cohort study. PLoS ONE. 2015;10(9):e0137592. DOI:10.1371/journal.pone.0137592
   PubMed Web of Science ®Google Scholar
• Trajman A, Luiz RR. McNemar chi2 test revisited: comparing sensitivity and specificity of diagnostic examinations. Scand J Clin Lab Invest. 2008;68(1):77–80.
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Baggett HC, Brooks WA, et al. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. 2019;394(10200):757–779. DOI:10.1016/S0140-6736(19)30721-4.
   PubMed Web of Science ®Google Scholar
• Nigrovic LE, Bennett JE, Balamuth F, et al. Accuracy of clinician suspicion of lyme disease in the emergency department. Pediatrics. 2017;140(6): DOI:10.1542/peds.2017-1975
   Web of Science ®Google Scholar
• Muller MP, Tomlinson G, Marrie TJ, et al. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia? Clin Infect Dis. 2005;40(8):1079–1086. DOI:10.1086/428577
   PubMed Web of Science ®Google Scholar
• Bijlsma MW, Brouwer MC, Bossuyt PM, et al. Risk scores for outcome in bacterial meningitis: systematic review and external validation study. J Infect. 2016;73(5):393–401. DOI:10.1016/j.jinf.2016.08.003
   PubMed Web of Science ®Google Scholar
• Gillette MA, Mani DR, Uschnig C, et al. Biomarkers to distinguish bacterial from viral pediatric clinical pneumonia in a malaria-endemic setting. Clin Infect Dis. 2021;73(11):e3939–3948. DOI:10.1093/cid/ciaa1843
   PubMed Web of Science ®Google Scholar
• Valim C, Ahmad R, Lanaspa M, et al. Responses to bacteria, virus, and malaria distinguish the etiology of pediatric clinical pneumonia. Am J Respir Crit Care Med. 2016;193(4):448–459. DOI:10.1164/rccm.201506-1100OC
   PubMed Web of Science ®Google Scholar
• Florin TA, Ambroggio L, Brokamp C, et al. Proadrenomedullin predicts severe disease in children with suspected community-acquired pneumonia. Clinl Infect Dis. 2021;73(3):E524–530. DOI:10.1093/cid/ciaa1138
   PubMed Web of Science ®Google Scholar
• Florin TA, Ambroggio L, Brokamp C, et al. Biomarkers and disease severity in children with community-acquired pneumonia. Pediatrics. 2020;145(6): DOI:10.1542/peds.2019-3728
   Web of Science ®Google Scholar
• Wilson ML. Malaria rapid diagnostic tests. Clin Infect Dis. 2012;54(11):1637–1641.
   PubMed Web of Science ®Google Scholar
• van Griensven J, Cnops L, De Weggheleire A, et al. Point-of-care biomarkers to guide antibiotic prescription for acute febrile illness in Sub-Saharan Africa: promises and caveats. Open Forum Infect Dis. 2020;7(8):ofaa260.
   PubMed Web of Science ®Google Scholar
• WHO. Child growth standards: weight-for-age. World Health Organization. [cited 2022 July 5]. Available from: https://www.who.int/tools/child-growth-standards/standards/weight-for-age
   Google Scholar
• WHO. Technical bases for the WHO recommendations on the management of pneumonia in children at first-level health facilities. Geneva: World Health Organization. 1991.
   Google Scholar